<DOC>
	<DOCNO>NCT00004659</DOCNO>
	<brief_summary>OBJECTIVES : I . Evaluate whether stereotactic radiosurgery provide local control multiple sit patient primary metastatic brain tumor , control systemic disease , preserve neurologic function . II . Examine survival , clinical outcome , local tumor image response patient .</brief_summary>
	<brief_title>Phase II Randomized Study Stereotactic Radiosurgery Plus Fractionated Whole-Brain Radiotherapy Vs Fractionated Whole-Brain Radiotherapy Alone Multiple Primary Metastatic Brain Tumors</brief_title>
	<detailed_description>PROTOCOL OUTLINE : This randomize study . Tumor size number confirm prior randomization . Patients stratify participate institution . Patients randomly assign 1 2 treatment group . One group treat fractionated whole-brain irradiation use megavoltage equipment . The second group receive stereotactic radiosurgery plus fractionated whole-brain radiotherapy . Stereotactic radiosurgery involve irradiation tumor margin stereotactic computerized tomography magnetic resonance imaging . Either treatment may administer first ; second treatment begin within 1 month first . Concurrent anticonvulsant steroid allow . Patients follow change size number tumor 1 , 3 , 6 month ; follow-up clinical exam perform least every 2 month .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>Multiple newly diagnose brain tumor Histologic confirmation carcinoma primary metastatic site Tumors less 25 mm mean diameter 5 mm optic chiasm No 4 tumor magnetic resonance image Systemic disease control Neurologic function preserve Radiographic stag within 2 month randomization require Performance status : Karnofsky 70 % 100 %</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1999</verification_date>
	<keyword>adult brain tumor</keyword>
	<keyword>brain tumor</keyword>
	<keyword>childhood brain tumor</keyword>
	<keyword>genetic condition</keyword>
	<keyword>nervous tissue tumor</keyword>
	<keyword>oncologic disorder</keyword>
	<keyword>rare disease</keyword>
</DOC>